Photobiomodulation as a Treatment in Dry AMD
By HakanKaymak, MD; and HartmutSchwahn, PhD

The development of innovative treatments for debilitating diseases such as age-related macular degeneration (AMD) is crucial to advance patient care and to reduce burdens on patients, caregivers, and physicians. The dry, or nonexudative, form of AMD affects approximately 85% to 90% of individuals with AMD, and, until now, there have been no approved treatments for…

Read More